Search - tctmd.com

Displaying 681 - 700 of 1391

Sort: Relevancy | Date

Presentation TCT 2014

Case #2: Extraction of a Fractured Guidewire During NSTEMI Intervention

Presenter: Petr Kala, Josef Stasek, Alec S. Vahanian, Stanislav Juhas

September 14, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian, Pavel Cervinka

September 14, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian

September 14, 2014

Presentation TCT 2014

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian, Pavel Cervinka

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

Case #2: Multivessel Disease in an NSTEMI Patient

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Colin Berry

September 14, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Dean J. Kereiakes, Margaret B. McEntegart, Stuart Watkins, Keith G. Oldroyd

September 14, 2014

Presentation TCT 2014

Gender Difference in STEMI Outcomes: Myth or Reality?

Presenter: Luigi Salemme, Mohamed Sobhy, Patrizia Presbitero

September 13, 2014

Presentation TCT 2014

Stent Designs and STEMI: Are There Meaningful Differences?

Presenter: Luigi Salemme, Mohamed Sobhy, Carlo Briguori

September 13, 2014

Presentation TCT 2014

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Presenter: Luigi Salemme, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

Multivessel PCI in ACS Supported by ECMO

Presenter: Vladimir Ganyukov

September 13, 2014

Presentation TCT 2014

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

Presenter: Frederick Feit, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

STEMI: Treatment Strategies, Drugs, and Devices

Presenter: Tayo A. Addo, Marc Etienne Jolicoeur

September 13, 2014

Presentation TCT 2014

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Jurrien M. Ten Berg

September 13, 2014

Presentation TCT 2014

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Presenter: Patrick W. Serruys, George D. Dangas

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi

September 13, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, Olivier Muller

September 13, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Greg L. Kaluza, Niall T. Mulvihill, Thomas Pilgrim, Marco Roffi, Simon J. Walsh

September 13, 2014

Advertisement

Case #2: Extraction of a Fractured Guidewire During NSTEMI Intervention

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

How Did I Treat This Patient?

Case #2: Multivessel Disease in an NSTEMI Patient

How Did I Treat This Patient?

Gender Difference in STEMI Outcomes: Myth or Reality?

Stent Designs and STEMI: Are There Meaningful Differences?

STEMI Pharmacology: Ambulance, ER, Cath Lab, and CCU

Multivessel PCI in ACS Supported by ECMO

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

STEMI: Treatment Strategies, Drugs, and Devices

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Are GP IIb/IIIa Inhibitors Still Useful?

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content